David B Clause, MD | |
4015 I 49 S Service Rd, Opelousas, LA 70570-0757 | |
(337) 942-6503 | |
(337) 942-8831 |
Full Name | David B Clause |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 32 Years |
Location | 4015 I 49 S Service Rd, Opelousas, Louisiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295734465 | NPI | - | NPPES |
1823104 | Medicaid | LA | |
P00881766 | Other | LA | MEDICARE RR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | 021674 (Louisiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Landry Homecare | Opelousas, LA | Home health agency |
Acadian Homecare, Llc | Lafayette, LA | Home health agency |
Opelousas General Health System | Opelousas, LA | Hospital |
Mercy Regional Medical Center | Ville platte, LA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Opelousas General Health System Physician Practices | 9830340694 | 45 |
News Archive
A strip of glass covered in hairy nanoparticles can cheaply and conveniently measure mercury, which attacks the nervous system, and other toxic metals in fluids.
The Medical Research Council (MRC) is to fund a research proposal from a team at the North East England Stem Cell Institute (NESCI) for a project to find ways of improving the efficiency of therapeutic cloning - a technique which would allow scientists to create patient-specific stem cells and develop regenerative therapies for many debilitating conditions such as diabetes, heart disease and Parkinson's disease.
Alzheimer's Research UK is calling for a recommitment from pharmaceutical companies to continue efforts to fund research into dementia, the leading cause of death in the UK.
Hospitalized patients who experience acute kidney problems that require dialysis are at increased risk of receiving chronic dialysis once discharged, but do not have an increased risk of death, according to a study in the September 16 issue of JAMA.
An 88-year-old man at The Methodist Hospital in Houston is one of two patients in the world today to receive an investigational eye drop that may restore sight for those suffering from neovascular (wet) age-related macular degeneration, a major cause of central visual loss and one of the leading causes of blindness in people over 60 in the United States.
› Verified 5 days ago
Entity Name | Opelousas Orthopaedic Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700964764 PECOS PAC ID: 2567473002 Enrollment ID: O20080428000039 |
News Archive
A strip of glass covered in hairy nanoparticles can cheaply and conveniently measure mercury, which attacks the nervous system, and other toxic metals in fluids.
The Medical Research Council (MRC) is to fund a research proposal from a team at the North East England Stem Cell Institute (NESCI) for a project to find ways of improving the efficiency of therapeutic cloning - a technique which would allow scientists to create patient-specific stem cells and develop regenerative therapies for many debilitating conditions such as diabetes, heart disease and Parkinson's disease.
Alzheimer's Research UK is calling for a recommitment from pharmaceutical companies to continue efforts to fund research into dementia, the leading cause of death in the UK.
Hospitalized patients who experience acute kidney problems that require dialysis are at increased risk of receiving chronic dialysis once discharged, but do not have an increased risk of death, according to a study in the September 16 issue of JAMA.
An 88-year-old man at The Methodist Hospital in Houston is one of two patients in the world today to receive an investigational eye drop that may restore sight for those suffering from neovascular (wet) age-related macular degeneration, a major cause of central visual loss and one of the leading causes of blindness in people over 60 in the United States.
› Verified 5 days ago
Entity Name | Opelousas General Health System Physician Practices |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1295098747 PECOS PAC ID: 9830340694 Enrollment ID: O20121105000236 |
News Archive
A strip of glass covered in hairy nanoparticles can cheaply and conveniently measure mercury, which attacks the nervous system, and other toxic metals in fluids.
The Medical Research Council (MRC) is to fund a research proposal from a team at the North East England Stem Cell Institute (NESCI) for a project to find ways of improving the efficiency of therapeutic cloning - a technique which would allow scientists to create patient-specific stem cells and develop regenerative therapies for many debilitating conditions such as diabetes, heart disease and Parkinson's disease.
Alzheimer's Research UK is calling for a recommitment from pharmaceutical companies to continue efforts to fund research into dementia, the leading cause of death in the UK.
Hospitalized patients who experience acute kidney problems that require dialysis are at increased risk of receiving chronic dialysis once discharged, but do not have an increased risk of death, according to a study in the September 16 issue of JAMA.
An 88-year-old man at The Methodist Hospital in Houston is one of two patients in the world today to receive an investigational eye drop that may restore sight for those suffering from neovascular (wet) age-related macular degeneration, a major cause of central visual loss and one of the leading causes of blindness in people over 60 in the United States.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
David B Clause, MD 4015 I 49 S Service Rd, Opelousas, LA 70570-0757 Ph: (337) 942-6503 | David B Clause, MD 4015 I 49 S Service Rd, Opelousas, LA 70570-0757 Ph: (337) 942-6503 |
News Archive
A strip of glass covered in hairy nanoparticles can cheaply and conveniently measure mercury, which attacks the nervous system, and other toxic metals in fluids.
The Medical Research Council (MRC) is to fund a research proposal from a team at the North East England Stem Cell Institute (NESCI) for a project to find ways of improving the efficiency of therapeutic cloning - a technique which would allow scientists to create patient-specific stem cells and develop regenerative therapies for many debilitating conditions such as diabetes, heart disease and Parkinson's disease.
Alzheimer's Research UK is calling for a recommitment from pharmaceutical companies to continue efforts to fund research into dementia, the leading cause of death in the UK.
Hospitalized patients who experience acute kidney problems that require dialysis are at increased risk of receiving chronic dialysis once discharged, but do not have an increased risk of death, according to a study in the September 16 issue of JAMA.
An 88-year-old man at The Methodist Hospital in Houston is one of two patients in the world today to receive an investigational eye drop that may restore sight for those suffering from neovascular (wet) age-related macular degeneration, a major cause of central visual loss and one of the leading causes of blindness in people over 60 in the United States.
› Verified 5 days ago
Mr. Thomas Reed Butaud, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4015 Hwy I 49 South Service Rd, Opelousas, LA 70570 Phone: 337-942-6503 Fax: 337-942-8831 | |
Mr. Gary L Porubsky, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4015 Hwy I-49 South Service Rd, Opelousas, LA 70570 Phone: 337-942-6503 Fax: 337-942-8831 | |
Dr. George Raymond Williams, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1233 Wayne Gilmore Circle, Suite 250-a, Opelousas, LA 70570 Phone: 337-948-8556 Fax: 337-948-6881 |